Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$501M |
| 2 |
UnitedHealth
UNH
|
+$307M |
| 3 |
Global Payments
GPN
|
+$302M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$279M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$433M |
| 2 |
Lam Research
LRCX
|
+$373M |
| 3 |
Pfizer
PFE
|
+$354M |
| 4 |
Verizon
VZ
|
+$341M |
| 5 |
EA
Electronic Arts
EA
|
+$305M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.18% |
| 2 | Healthcare | 10.69% |
| 3 | Financials | 10.58% |
| 4 | Industrials | 8.45% |
| 5 | Consumer Discretionary | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
CACI
CACI
$14.3B
| $130M | 0.04% |
414,902
-23,435
| -5% | -$7.84M |
|
402
First Industrial Realty Trust
FR
$8.36B
| $130M | 0.04% |
2,790,770
-42,375
| -1% | -$2.18M |
|
403
Northern Trust
NTRS
$34.4B
| $129M | 0.04% |
1,863,009
-1,064,037
| -36% | -$80.4M |
|
404
SPX Corp
SPXC
$10.6B
| $129M | 0.04% |
1,579,646
+165,544
| +12% | +$13.3M |
|
405
Chemed
CHE
$7.18B
| $128M | 0.04% |
247,601
-32,832
| -12% | -$17.1M |
|
406
Lumentum
LITE
$63.3B
| $128M | 0.04% |
2,830,457
+149,738
| +6% | +$7.6M |
|
407
Gilead Sciences
GILD
$165B
| $128M | 0.04% |
1,703,783
+115,189
| +7% | +$8.86M |
|
408
Johnson Controls International
JCI
$91.3B
| $127M | 0.04% |
2,387,899
+618,920
| +35% | +$38.2M |
|
409
Expedia Group
EXPE
$37.7B
| $127M | 0.04% |
1,229,820
-1,082,175
| -47% | -$119M |
|
410
Lattice Semiconductor
LSCC
$18.2B
| $127M | 0.04% |
1,474,497
+107,100
| +8% | +$9.67M |
|
411
Illumina
ILMN
$29B
| $127M | 0.04% |
948,274
+113,221
| +14% | +$18.6M |
|
412
Churchill Downs
CHDN
$6.02B
| $126M | 0.04% |
1,086,275
+83,214
| +8% | +$10.3M |
|
413
Alnylam Pharmaceuticals
ALNY
$29B
| $125M | 0.04% |
706,200
+80,862
| +13% | +$15.4M |
|
414
ATI
ATI
$31.1B
| $125M | 0.04% |
3,036,735
-22,055
| -0.7% | -$980K |
|
415
Invesco Preferred ETF
PGX
$3.76B
| $125M | 0.04% |
11,354,319
-1,139,197
| -9% | -$12.7M |
|
416
iShares MSCI Emerging Markets ex China ETF
EMXC
$23.8B
| $124M | 0.04% |
3,142,892
+740,308
| +31% | +$38.4M |
|
417
iShares Russell 3000 ETF
IWV
$20.4B
| $124M | 0.04% |
504,563
-262,134
| -34% | -$67M |
|
418
Burford Capital
BUR
$940M
| $123M | 0.04% |
9,146,638
-1,150,422
| -11% | -$15.7M |
|
419
Coty
COTY
$2.51B
| $121M | 0.04% |
11,060,293
+406,769
| +4% | +$4.79M |
|
420
PayPal
PYPL
$50.5B
| $121M | 0.04% |
2,070,469
-18,674
| -0.9% | -$1.22M |
|
421
Hartford Multifactor US Equity ETF
ROUS
$725M
| $121M | 0.04% |
3,001,944
-679,781
| -18% | -$28.3M |
|
422
BJs Wholesale Club
BJ
$12.3B
| $121M | 0.04% |
1,688,394
+467,575
| +38% | +$31.5M |
|
423
Schwab US TIPS ETF
SCHP
$16.2B
| $120M | 0.04% |
4,717,634
-725,008
| -13% | -$18.7M |
|
424
Everest Group
EG
$14.2B
| $120M | 0.04% |
320,126
+56,995
| +22% | +$20.7M |
|
425
Vanguard Tax-Exempt Bond Index Fund
VTEB
$46B
| $119M | 0.04% |
2,480,741
+298,313
| +14% | +$14.8M |
|
Similar funds
Ameriprise's Q3 2023 Portfolio in Review
As of Q3 2023, Ameriprise held 4,031 positions worth $305B, down 4.5% from $319B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Ameriprise's Q3 2023 filing shows 127 new, 1,527 increased, 2,081 reduced and 148 closed positions. Its largest new stake was TKO Group: 772,651 shares worth $64.9M. The largest sale was Johnson & Johnson, an estimated $433M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q3 2023 buy was TKO Group: 772,651 shares worth $64.9M.
- Ameriprise added most to AT&T in Q3 2023, an estimated $501M increase.
- Ameriprise's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $433M.
- Ameriprise fully exited NiSource Inc. Series A Corporate Units in Q3 2023, selling an estimated $73.8M.
- Ameriprise's ten largest holdings make up 16% of its $305B portfolio in Q3 2023.
- Ameriprise opened 127 new positions and closed 148 in Q3 2023.
- Ameriprise's portfolio value fell 4.5% quarter-over-quarter to $305B.
Based on Ameriprise's 13F filing for Q3 2023, filed 14 Nov 2023.